Trial Details

TERMINATED
Basic Information
Clinical ID c2479
Identifier NCT03440372
Trial Title Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: Ozanimod|OTHER: Placebo
Participant Information
Sponsor Celgene
City Peoria
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2018-02-27
Primary Completion Date 2024-10-01
Completion Date 2024-10-01